Literature DB >> 31604107

Hyperandrogenemia and insulin resistance: The chief culprit of polycystic ovary syndrome.

Juan Wang1, Daichao Wu1, Hui Guo1, Meixiang Li2.   

Abstract

Polycystic ovary syndrome (PCOS) is one of the most common systemic reproductive endocrine diseases, which has a variety of effects on a woman's health. Because of the involvement of multiple pathways and the lack of common clues, PCOS demonstrates multifactorial properties and heterogeneity of symptoms. Recent studies have demonstrated that the core etiology and primary endocrine characteristics of PCOS are hyperandrogenemia (HA) and insulin resistance (IR). HA and IR are the main causes of PCOS and they can interplay each other in the occurrence and development of PCOS. Just because of this, the study about the effects of HA and IR on pathophysiology of various related symptoms of PCOS is very important to understand the pathogenesis of PCOS. This paper reviews the main symptoms of PCOS, including neuroendocrine disorders, reproductive processes, dyslipidemia, obesity, hypertension, nonalcoholic fatty liver disease (NAFLD), and sleep disordered breathing, which seriously affect the physical and mental health of PCOS women. The increasing knowledge of the development pattern of HA and IR in PCOS suggests that changes in diet and lifestyle, and the discovery of potential therapeutic agents may improve PCOS. However, further studies are needed to clarify the mutual influence and relation of HA and IR in development of PCOS. This review provides an overview of the current knowledge about the effects of HA and IR on PCOS.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Advanced glycosylation end products; Endocrine disrupting chemicals; Hyperandrogenemia; Insulin resistance; PCOS

Mesh:

Year:  2019        PMID: 31604107     DOI: 10.1016/j.lfs.2019.116940

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  39 in total

1.  Serum metabolomics reveals metabolic profiling for women with hyperandrogenism and insulin resistance in polycystic ovary syndrome.

Authors:  Zhihao Zhang; Yanli Hong; Minmin Chen; Ninghua Tan; Shijia Liu; Xiaowei Nie; Wei Zhou
Journal:  Metabolomics       Date:  2020-01-24       Impact factor: 4.290

2.  Controversies surrounding female athletes with differences in sexual development.

Authors:  Ahmed Khattab; Ian Marshall; Sally Radovick
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

3.  Role of CPXM1 in Impaired Glucose Metabolism and Ovarian Dysfunction in Polycystic Ovary Syndrome.

Authors:  Sadaf Pervaz; Amin Ullah; Enoch Appiah Adu-Gyamfi; Jones Lamptey; Sanjay Kumar Sah; Mei-Jiao Wang; Ying-Xiong Wang
Journal:  Reprod Sci       Date:  2022-06-13       Impact factor: 3.060

Review 4.  Effects of Sitagliptin on Metabolic Indices and Hormone Levels in Polycystic Ovary Syndrome: a Meta-analysis of Randomized Controlled Trials.

Authors:  Lijuan Zhang; Airong Chen; Jing Lu; Liuliu Ren; Zelin Hu
Journal:  Reprod Sci       Date:  2022-08-12       Impact factor: 2.924

Review 5.  The Role of Genetics, Epigenetics and Lifestyle in Polycystic Ovary Syndrome Development: the State of the Art.

Authors:  Vincenzina Bruni; Anna Capozzi; Stefano Lello
Journal:  Reprod Sci       Date:  2021-03-11       Impact factor: 3.060

Review 6.  A Narrative Review of Current Understanding of the Pathophysiology of Polycystic Ovary Syndrome: Focus on Plausible Relevance of Vitamin D.

Authors:  Rajeshwari Kalyanaraman; Lubna Pal
Journal:  Int J Mol Sci       Date:  2021-05-05       Impact factor: 5.923

7.  Effects of atorvastatin on the insulin resistance in women of polycystic ovary syndrome: A systematic review and meta-analysis.

Authors:  Lin-Lin Chen; Jian-Hong Zheng
Journal:  Medicine (Baltimore)       Date:  2021-06-18       Impact factor: 1.817

Review 8.  Autophagy in ovary and polycystic ovary syndrome: role, dispute and future perspective.

Authors:  Sanjana Kumariya; Vaibhave Ubba; Rajesh K Jha; Jiaur R Gayen
Journal:  Autophagy       Date:  2021-06-23       Impact factor: 13.391

Review 9.  An Update on the Progress of Endometrial Receptivity in Women with Polycystic Ovary Syndrome.

Authors:  Jinyan Zhao; Qing Chen; Xiang Xue
Journal:  Reprod Sci       Date:  2021-06-02       Impact factor: 2.924

10.  Associations of Serum Magnesium With Insulin Resistance and Testosterone in Women With Polycystic Ovary Syndrome.

Authors:  Xi Luo; Wang-Yu Cai; Hong-Li Ma; Jing Cong; Hui Chang; Jing-Shu Gao; Wen-Juan Shen; Yu Wang; Xin-Ming Yang; Xiao-Ke Wu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-23       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.